Latest WEHI News

New guidelines set to change the way we diagnose type 1 diabetes
Robots help put brakes on inflammatory diseases: study unveils new automated diagnostic techniques
Medical Research Future Fund supports new biotech company tackling hard-to-treat cancers
New Biotech Company Tackles Hard-to-treat Cancers
WEHI spinout company set to revolutionise homegrown cancer treatments
Pancreatic cancer research receives $8m philanthropic funding boost
Ubiquitin trailblazer elected Fellow of prestigious Royal Society
Eliminating Malaria In Our Region
A $411 million commitment for researchers to bring their discoveries to life
One-two punch treatment delivers blood cancer knockout
New arrivals boost Hudson’s inflammation research leadership
Constitutional complaint brought against Federal Court Judge for concealing pharma connections
Protein discovery sparks treatment hope for aggressive cancer
Australian Institute for Infectious Disease (AIID) announces early works contractor
New insight into gene uncovers its link to incurable birth defect
Lab-grown tumours predict treatment outcomes in landmark study
Discovery of drug candidate to potentially tackle ER-positive breast cancer
Hudson Institute welcomes inflammation specialist as new Centre Head
Pelvic organ prolapse pioneer gets funding to find fix
Cracking the code: researchers unravel how mutant protein drives cancer growth
New director for WEHI
Landmark blood test to detect silent, lethal cancer
New national centre to transform Australia’s homegrown medicine capabilities launches in Melbourne
Medchem game changer in identifying lifesaving new drugs
Researcher’s work on ‘kiss of death’ protein gets industry accolades
New $15m frontier technology centre to develop next-generation cancer drugs
When cells go boom: study reveals inflammation-causing gene carried by millions
Novel therapeutics development highlighted in Australasian Biotechnology journal
The Leukaemia Foundation and Tour de Cure announce Breakthrough Research Fellowships in bid to save more lives
Chance discovery shows promise in finding treatment for genetic disorder
Eureka win for researchers behind new anti-cancer strategy
Birdwatching, immune responses and evolutionary mapping honoured at 2023 Eureka Prizes
New national venture strengthens home-grown medicine outcomes
Drug discovery gets $9.75m boost for MedChem Australia
Finding rewrites understanding into Parkinson’s disease pathway
The new ‘Jumar Bioincubator’ calls for biotechnology start-ups
Leading biologist and Academy Fellow appointed CSIRO Chief Executive
WEHI’s Professor Doug Hilton appointed chief executive of CSIRO
New appointment for WEHI director
Trailblazing researchers recognised in King’s Birthday honours
New action plan strengthens reconciliation commitment
Pioneering ubiquitin researcher inducted as Academy Fellow
Academy welcomes 20 new Fellows for their outstanding contributions to science
Funding boost advances research on cancer vaccine
Advanced immunotherapy treatment may hold promise for children with brain cancer
Study shows benefit of universal genetic testing after breast cancer diagnosis
New insights into preventing malaria
Landmark Malawi trial boosts iron levels in pregnant women